SCHEMBL10246014

SCHEMBL10246014

Nc1ccc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 7/20 0.76
VCP P55072 4/20 0.76
HSPD1 P10809 1/20 0.68
HSPE1 P61604 1/20 0.68
AMY1A P0DUB6 3/20 0.63
MAPT P10636 5/20 0.63
GAA P10253 4/20 0.63
ALDH1A1 P00352 3/20 0.63
NPSR1 Q6W5P4 3/20 0.63
LMNA P02545 2/20 0.63
HTT P42858 2/20 0.63
NPC1 O15118 2/20 0.63
RAB9A P51151 2/20 0.63
CFTR P13569 1/20 0.60
ABL1 P00519 3/20 0.55
KDM4E B2RXH2 2/20 0.55
POLB P06746 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
MEN1 O00255 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205976 0.89 ALOX5 (0.80) ALOX5VCPAMY1AMAPTGAA
SCHEMBL5325600 0.86 ALOX5 (1.00) ALOX5VCPAMY1AMAPTGAA
SCHEMBL2755470 0.85 VCP (1.00) ALOX5VCPHSPD1HSPE1AMY1A
SCHEMBL208320 0.83 VCP (0.71) ALOX5VCPAMY1AMAPTGAA
SCHEMBL4558920 0.83 ALOX5 (0.71) ALOX5VCPAMY1AMAPTGAA
SCHEMBL2208135 0.81 ABL1 (0.77) ALOX5VCPMAPTGAAALDH1A1
SCHEMBL207355 0.81 ALOX5 (0.68) ALOX5VCPAMY1AMAPTGAA
SCHEMBL208192 0.81 ALOX5 (0.72) ALOX5VCPAMY1AMAPTNPC1
SCHEMBL206333 0.80 ALOX5 (0.77) ALOX5VCPAMY1AMAPTGAA
Bromide SCHEMBL2209661 0.80 ABL1 (0.76) ALOX5VCPMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885HSPD1 3658/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885HSPD1 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.